Periodontal Disease Predicts CAC Progression in Type 1 Diabetes

This article originally appeared here.
Share this content:
Periodontal Disease Predicts CAC Progression in Type 1 Diabetes
Periodontal Disease Predicts CAC Progression in Type 1 Diabetes

MONDAY, Aug. 31, 2015 (HealthDay News) -- In patients with type 1 diabetes, but not those without diabetes, periodontal disease duration is an independent predictor of long-term progression of coronary artery calcium (CAC), according to a study published in the Sept. 15 issue of The American Journal of Cardiology.

Daniel W. Groves, M.D., from the University of Colorado-Denver in Aurora, and colleagues examined the interrelation between periodontal disease and CAC progression in individuals with and without type 1 diabetes. The prevalence and progression of CAC was assessed in relation to self-reported periodontal disease. During a mean of 6.1 years, 473 patients with type 1 diabetes and 548 without diabetes were followed.

The researchers observed no difference in the prevalence and duration of periodontal disease at baseline for subjects with versus without diabetes (14.5 versus 13.4 percent; P = 0.60; six versus nine years; P = 0.18). There was no significant association observed between duration of periodontal disease and baseline CAC prevalence. Periodontal disease duration was significantly related to CAC progression in patients with type 1 diabetes (P = 0.004), but not in those without diabetes (P = 0.63).

"In conclusion, this study suggests that periodontal disease is an independent predictor of long-term progression of CAC in patients with type 1 diabetes," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »